Abstract

Varicella Zoster Virus is a type of Human Alpha herpes Virus which usually cause Chicken Pox in Children and most commonly presents as shingles in the adult patient as dermatological Disease which are painful Vesicular Skin Eruptions Localized to a specific dermatome of the body also known as Herpes Zoster. One of the rare and dreaded Complication of Varicella Zoster Infection is involvement of the Central Nervous System causing varicella zoster virus encephalitis (Vze). Vze was often underdiagnosed earlier due to its Nonspecific clinical presentation but in present Era Polymerase Chain Reaction for Detecting Viral Particles in cerebrospinal fluid Provides a rapid and accurate Means of Diagnosis. In this case report, one Patient with Vze Diagnosed by a positive cerebrospinal fluid polymerase Chain Reaction and the Literature is reviewed and we discussed his Clinical History and Physical Exam findings that should raise clinical suspicion for Varicella Zoster Encephalitis, as well as epidemiology, risk factors, diagnosis and Treatment of this Type of Infection. We Provide a detailed approach to the Diagnosis and treatment of Vze.

• 1.   Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices (ACIP). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-5):1–30.
• 2.   Ku CC, Besser J, Abendroth A, et al. Varicella-zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model. J Virol. 2005;79(5):2651-2658.
• 3.   World Health Organization. Varicella and herpes zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol Rec. 2014;89(25):265–287.
• 4.   Levin MJ. Varicella-zoster virus and virus DNA in the blood and oropharynx of people with latent or active varicella-zoster virus infections. J Clin Virol. 2014;61(4):487–495.
• 5.   de Melker H, Berbers G, Hahné S, et al. The epidemiology of varicella and herpes zoster in the Netherlands: implications for varicella zoster virus vaccination. Vaccine. 2006;24(18):3946–3952.
• 6.   Gilden D. Varicella zoster virus and central nervous system syndromes. Herpes. 2004;11 Suppl 2:89A-94A.
• 7.   Hughes BA, Kimmel DW, Aksamit AJ. Herpes zoster-associated meningoencephalitis in patients with systemic cancer. Mayo Clin Proc. 1993;68(7):652-655.
• 8.   Bower JH, Hammack JE, McDonnell SK, et al. The neurologic complications of B-cell lymphocytic leukemia. Neurology. 1997;48(2):407-412.
• 9.   Elliott KJ. Other neurological complications of herpes zoster and their management. Ann Neurol. 1994;35 Suppl:S57-S61.
• 10.   Tenser RB. Herpes simplex and herpes zoster: nervous system involvement. Neurol Clin. 1984;2(2):215-240.
• 11.   Guidetti D, Gabbi E, Motti L, et al. Neurological complications of herpes zoster. Ital J Neurol Sci. 1990;11(6):559-565.
• 12.   Harbecke R, Oxman MN, Arnold BA, et al. A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses. J Med Virol. 2009;81(7):1310–1322.
• 13.   Kleinschmidt-DeMasters BK, Amlie-Lefond C, Gilden DH. The patterns of varicella zoster virus encephalitis. Hum Pathol. 1996;27(9):927-938.

Data Sharing Statement

Funding